Peptide Registry

MOTS-c (Capsules)

Price range: $99.00 through $179.00

  • Contents: MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c; 16-amino acid mitochondrial peptide)
  • Format: Encapsulated solid
  • Appearance: White to off-white solid
  • Purity: >99%
Quantity Discount Price
1 - 3 - -
4 - 7 10% -
8 + 18% -
SKU: N/A Category: Brand:

Description

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded within the 12S rRNA of the mitochondrial genome. Upon cellular stress, it translocates to the nucleus, where it regulates AMPK-mediated metabolic signaling and antioxidant gene expression programs. MOTS-c in capsule format is designed for oral administration research protocols. Oral bioavailability data for MOTS-c capsules are limited compared to parenteral routes; researchers should design appropriate controls when comparing oral and parenteral administration conditions in their experimental models.

Storage and Handling

Store in a cool, dry place away from heat, moisture, and direct light. Keep container tightly sealed when not in use. Refer to the lot-specific certificate of analysis for recommended storage conditions.

Compliance Notice

MOTS-c capsules are supplied for laboratory research use only. They are not intended for human or veterinary use and carry no therapeutic, diagnostic, or clinical indication. This product has not been evaluated by the FDA. By purchasing this product, the buyer confirms it will be used exclusively for controlled research by qualified personnel following appropriate institutional safety procedures.

Frequently Asked Questions

What should researchers consider when using MOTS-c in capsule format?

MOTS-c is a 16-amino acid peptide. Published MOTS-c research has predominantly used parenteral administration. Oral peptide absorption depends on gastric stability and intestinal transport mechanisms that have not been extensively characterized for this compound. Researchers using capsule format should not assume equivalent bioavailability to parenteral routes without supporting pharmacokinetic data.

How do the 500mcg and 1000mcg capsule options support research design?

The two dose options allow AMPK pathway dose-response studies without custom weighing, supporting comparative experimental designs with consistent compound handling across sessions.